These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38136996)

  • 1. Prognostic Value of Genotype-Phenotype Correlations in X-Linked Myotubular Myopathy and the Use of the Face2Gene Application as an Effective Non-Invasive Diagnostic Tool.
    Kušíková K; Šoltýsová A; Ficek A; Feichtinger RG; Mayr JA; Škopková M; Gašperíková D; Kolníková M; Ornig K; Kalev O; Weis S; Weis D
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38136996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked myotubular myopathy mimics hereditary spastic paraplegia in two female manifesting carriers of pathogenic MTM1 variant.
    Kraatari M; Tuominen H; Tuupanen S; Haapaniemi T; Moilanen J; Rahikkala E
    Eur J Med Genet; 2020 Nov; 63(11):104040. PubMed ID: 32805447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
    Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
    Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-Linked Myotubular Myopathy: A Novel Mutation Expanding the Genotypic Spectrum of a Phenotypically Heterogeneous Myopathy.
    Carvalho A; Costa C; Pinto M; Taipa R; Gonçalves A; Oliveira ME; Ferreira S; Ribeiro JA
    J Pediatr Genet; 2023 Sep; 12(3):258-262. PubMed ID: 37575650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation spectrum of the MTM1 gene in XLMTM patients: 10 years of experience in prenatal and postnatal diagnosis.
    Longo G; Russo S; Novelli G; Sangiuolo F; D'Apice MR
    Clin Genet; 2016 Jan; 89(1):93-8. PubMed ID: 26338224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy.
    Bryen SJ; Oates EC; Evesson FJ; Lu JK; Waddell LB; Joshi H; Ryan MM; Cummings BB; McLean CA; MacArthur DG; Kornberg AJ; Cooper ST
    Eur J Hum Genet; 2021 Jan; 29(1):61-66. PubMed ID: 32862205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations.
    Tosch V; Vasli N; Kretz C; Nicot AS; Gasnier C; Dondaine N; Oriot D; Barth M; Puissant H; Romero NB; Bönnemann CG; Heller B; Duval G; Biancalana V; Laporte J
    Neuromuscul Disord; 2010 Jun; 20(6):375-81. PubMed ID: 20434914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an MTM1-mutant iPSC line (CRICKi008-A) from an individual with X-linked myotubular myopathy (XLMTM).
    Devito LG; Lionello VM; Muntoni F; Tedesco FS; Healy L
    Stem Cell Res; 2023 Jun; 69():103079. PubMed ID: 36989620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three novel MTM1 pathogenic variants identified in Japanese patients with X-linked myotubular myopathy.
    Nishikawa A; Iida A; Hayashi S; Okubo M; Oya Y; Yamanaka G; Takahashi I; Nonaka I; Noguchi S; Nishino I
    Mol Genet Genomic Med; 2019 May; 7(5):e621. PubMed ID: 30884204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of X-linked myotubular myopathy by detection of myotubularin.
    Laporte J; Kress W; Mandel JL
    Ann Neurol; 2001 Jul; 50(1):42-6. PubMed ID: 11456308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy.
    Hammans SR; Robinson DO; Moutou C; Kennedy CR; Dennis NR; Hughes PJ; Ellison DW
    Neuromuscul Disord; 2000 Feb; 10(2):133-7. PubMed ID: 10714588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Splicing Mutation in
    Bosco L; Leone D; Costa Comellas L; Monforte M; Pane M; Mercuri E; Bertini E; D'Amico A; Fattori F
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked myotubular myopathy: report of a case with novel mutation.
    Hortobágyi T; Szabó H; Kovács KS; Bódi I; Bereg E; Katona M; Biancalana V; Túri S; Sztriha L
    J Child Neurol; 2007 Apr; 22(4):447-51. PubMed ID: 17621527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims.
    Sacks NC; Healey BE; Cyr PL; Slocomb T; James E; Beggs AH; Graham RJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1019-1026. PubMed ID: 33843254
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
    Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial.
    Lawlor MW; Schoser B; Margeta M; Sewry CA; Jones KA; Shieh PB; Kuntz NL; Smith BK; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Blaschek A; Neuhaus S; Foley AR; Saade DN; Tsuchiya E; Qasim UR; Beatka M; Prom MJ; Ott E; Danielson S; Krakau P; Kumar SN; Meng H; Vanden Avond M; Wells C; Gordish-Dressman H; Beggs AH; Christensen S; Conner E; James ES; Lee J; Sadhu C; Miller W; Sepulveda B; Varfaj F; Prasad S; Rico S
    EBioMedicine; 2024 Jan; 99():104894. PubMed ID: 38086156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies.
    D'Amico A; Longo A; Fattori F; Tosi M; Bosco L; Chiarini Testa MB; Paglietti MG; Cherchi C; Carlesi A; Mizzoni I; Bertini E
    Orphanet J Rare Dis; 2021 Oct; 16(1):425. PubMed ID: 34641930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A healthcare claims analysis to identify and characterize patients with suspected X-Linked Myotubular Myopathy (XLMTM) in the Brazilian Healthcare System.
    Souza PVS; Haselkorn T; Baima J; Oliveira RW; Hernández F; Birck MG; França MC
    Orphanet J Rare Dis; 2024 May; 19(1):188. PubMed ID: 38715109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States.
    Graham RJ; Darras BT; Haselkorn T; Fisher D; Genetti CA; Miller W; Beggs AH
    Orphanet J Rare Dis; 2023 Jun; 18(1):138. PubMed ID: 37280644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy.
    Buj-Bello A; Biancalana V; Moutou C; Laporte J; Mandel JL
    Hum Mutat; 1999; 14(4):320-5. PubMed ID: 10502779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.